International Institute for Nanotechnology

Why We DoNanotechnology has opened the door to a world of innovative applications which were once only possible in science fiction. Its convergence with various technologies such as biotechnology, information technology, and cognitive science has been progressively impacting a wide range of industries, thereby playing a pivotal role in the advancement of future industries to the extent that it can be said:. Nanotechnology is not part of the future; it builds the whole future! Active involvement in the nano world necessitates making numerous decisions every single day; it is therefore of crucial importance to acquire a profound knowledge and track the latest developments in the fields of science, technology, innovation, and business. In-depth understanding of these fields requires access to the facts gathered based on reliable data and authentic information.

Nanotechnology is a new age of materials science. It is the technology of the future – a new paradigm to solving many problems, also most current and critical to the World. Are you interested in nanotechnology or thinking about bringing your commercial products into new dimensions?

The Institute of Nanoscience and Nanotechnology (INN) of the National Center for Scientific Research (NCSR) “Demokritos” was established in 2012 through the merging of three former Institutes, all established in 1986.

This is a new and unique technology introduction to South Africa, and part of the materials technology section of the Fourth Industrial Revolution. Nanotechnology enhances the efficiency of energy consumption and massively increases manufacturing production at significantly reduced costs. Products of nanotechnology are smaller, cheaper, lighter yet more functional, and require less energy and fewer raw materials in the manufacturing process.

The Interdisciplinary Nanoscience Center (iNANO) at Aarhus University is a modern research and education center which was founded by Professor Flemming Besenbacher in 2002. Since then iNANO has promoted research, education and knowledge transfer within nanoscience and nanotechnology with particular emphasis on collaboration across traditional disciplinary boundaries. In 2012 iNANO moved to the newly build and modern iNANO House, increasing the proximity between many collaborating research groups and providing space for an expansion of the necessary research infrastructure. The research at iNANO occurs mainly within five key strategic areas:. On 1 May, iNANO associated Professor Birgit Schiøtt will become dean of the Faculty of Natural Sciences. The state-of-the-art infrastructure platform at iNANO ranges from clean-room facilities for nanofabrication, over chemical synthesis to cell laboratories, and includes state-of-the art equipment for nanocharacterisation using microscopy, diffraction and spectroscopy techniques. The center hosts a multidisciplinary BSc and MSc program in Nanoscience as well as the PhD school iNANOschool.

In addition, we are advancing a therapeutic platform that induces antigen-specific tolerance to treat autoimmune diseases. We are determined to develop innovative drug delivery systems that enable the full therapeutic potential of various compounds as safe and effective nanomedicines. Integrated Nanotherapeutics (INT) is a biotech company in Vancouver, Canada focused on using nanotechnology to uncover and maximize the therapeutic potential of many drugs. Our proprietary drug delivery platform technology can deliver any type of drug modality in lipid nanoparticles (LNPs), either alone or in combination, to disease tissues and cells. Integrated Nanotherapeutics is founded by a team of world-class scientists with multi-disciplinary skills in basic science, preclinical research, drug development, and commercialization of therapeutics. We have collectively over 100 years of experience in lipid nanoparticle (LNP) science and drug development. We strive to become the leading nanomedicines company in the world and provide advanced, first-in-class therapies to many people. Our versatile drug delivery platform allows the incorporation of virtually any small molecule and/or biologic into lipid nanoparticles (LNPs).